BRCA2 c.8827C>T pathogenic mutation in a consanguineous Chinese family with hereditary breast cancer.

Molecular Genetics & Genomic Medicine
Jiangfen WangYafen Zhang

Abstract

Mutations in the BRCA2 DNA repair associated gene (BRCA2) are associated with the development of breast cancer, with different ethnic mutations at different sites. Based on different types of BRCA2 variants, the underlying mechanism remains still elusive. Next-generation sequencing (NGS) was performed to detect germ line mutations in BRCA2. The expressions of BRCA2 mRNA and BRCA2 protein were detected by Real-time PCR and Western blot, respectively. In a consanguineous Chinese family with hereditary breast cancer, one woman had unilateral breast cancer, two women had bilateral asynchronous breast cancer, and one man had prostate cancer. We identified a mutation site (NM_000059.4: c.8827C>T, NP_ 000050.3: p.(Gln2943*)) in BRCA2 gene, which was a nonsense mutation that predicted disrupting peptide chain synthesis and limiting BRCA2 protein production, validated by the decreased expressions of both BRCA2 mRNA and BRCA2 protein. In this study, we identified a BRCA2 c.8827C>T nonsense mutation with a truncated BRCA2 protein in a consanguineous Chinese Han family, suggesting individuals with this mutation should be regularly screened for malignancies such as breast, prostate, and ovarian cancer. Our study verified the function of thi...Continue Reading

References

Mar 1, 1996·Nature Genetics·S V TavtigianD E Goldgar
Mar 29, 2000·Biochemical and Biophysical Research Communications·K YanoY Miki
May 3, 2003·Current Opinion in Structural Biology·Yousif Shamoo
Jul 14, 2005·Biomedical Research·Yasunaga YoshikawaKazuyoshi Hashizume
Jun 16, 2007·Molecular Diagnosis & Therapy·Rachel Nusbaum, Claudine Isaacs
Oct 9, 2007·Journal of Human Genetics·Wafa TroudiA Ben Ammar Elgaaied
Feb 21, 2008·Familial Cancer·Rolando Comacho RodriguezSteven A Narod
Feb 10, 2011·Annals of Oncology : Official Journal of the European Society for Medical Oncology·R L Milne, A C Antoniou
Oct 29, 2011·International Journal of Cancer. Journal International Du Cancer·James D FackenthalOlufunmilayo I Olopade
Nov 6, 2014·Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology·Gabriela Torres-MejíaSteven A Narod
Apr 8, 2015·JAMA : the Journal of the American Medical Association·Timothy R RebbeckIrene Andrulis
Mar 17, 2016·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Xiao LiQing Zou
Aug 17, 2016·Endocrine-related Cancer·Roger L Milne, Antonis C Antoniou
Mar 23, 2017·Archives of Gynecology and Obstetrics·Cornelia MeiselKarin Kast

❮ Previous
Next ❯

Methods Mentioned

BETA
PCR
chip

Software Mentioned

Bandscan gel image
Picard
Genome Analysis Toolkit
Annovar
MuTect2
GraphPad Prism
GraphPad
BaseRecalibrator

Related Concepts

Related Feeds

Cancer Sequencing

Several sequencing approaches are employed to understand and examine tumor development and progression. These include whole genome as well as RNA sequencing. Here is the latest research on cancer sequencing.

Breast Cancer: BRCA1 & BRCA2

Mutations involving BRCA1, found on chromosome 17, and BRCA2, found on chromosome 13, increase the risk for specific cancers, such as breast cancer. Discover the last research on breast cancer BRCA1 and BRCA2 here.

Cancer Disparities

Cancer disparities refers to differences in cancer outcomes (e.g., number of cancer cases, related health complications) across population groups.